patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Re: Orphan Drug Designation for Pluristem's Aplastic Anemia Treatment Could Open $1.
Reply New Message
Back To Forum List View
Icon president Orphan Drug Designation for Pluristem's Aplastic Anemia Treatment Could Open $1.
1
emit
Aug 31, 2012 01:55PM

Love those time-frames... makes me want to buy more.

I think I will -

Have a super holiday everyone

e

Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply